Remarkable response of <i>BRAF</i>V600E-mutated metastatic pancreatic cancer to BRAF/MEK inhibition: a case report
Hong‐Shuai Li, Ke Yang, Yan Wang
Topics & Concepts
MedicineV600EPancreatic cancerVemurafenibCancer researchMetastatic melanomaMEK inhibitorCancerTrametinibInternal medicineOncologyMutationMelanomaMAPK/ERK pathwayGeneGeneticsKinaseBiologyMelanoma and MAPK PathwaysPancreatic and Hepatic Oncology ResearchCancer Genomics and Diagnostics